1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a metal ion (such as silver or platinum), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
3. Rule 3: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
Explanation:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the risk of adverse effects on the blood and lymphatic system. This is because nitro groups can interact with blood proteins and enzymes, which can lead to toxicity and adverse effects. Nitro groups are commonly found in drugs such as aspirin, which can cause stomach ulcers and bleeding.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the risk of adverse effects on the blood and lymphatic system. This is because carbonyl groups can react with blood proteins and enzymes, which can lead to toxicity and adverse effects. Carbonyl groups are commonly found in drugs such as acetaminophen, which can cause liver damage and other adverse effects.
3. Rule 3: The presence of a halogen atom (-F, -Cl, -Br, -I) in a molecule increases the risk of adverse effects on the blood and lymphatic system. This is because halogen atoms can interact with blood proteins and enzymes, which can lead to toxicity and adverse effects. Halogen atoms are commonly found in drugs such as thalidomide, which can cause birth defects and other adverse effects.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a nitro group, it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to blood and lymphatic system disorders.
Explanation:
1. The molecule contains a carboxylic acid group, which is a common functional group found in drugs that can cause adverse effects related to blood and lymphatic system disorders.
2. The molecule contains a nitro group, which is another common functional group found in drugs that can cause adverse effects related to blood and lymphatic system disorders.
3. The molecule contains a halogenated aromatic ring, which is a structural feature found in many drugs that can cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If a molecule contains a functional group such as an amide group (-C=O-NH-) or a carboxylic acid group (-COOH), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group (-NO2), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a functional group such as a halogen atom (-Cl, -Br, -I), it is more likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a nitro group, it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a benzene ring, it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a benzene ring, it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The molecule with label 0, C1CN(CC1C(C2=CC=CC=C2)(C3=CC=CC=C3)C(=O)N)CCC4=CC5=C(C=C4)OCC5, contains a chlorine atom. The molecule with label 1, CN(CC=CC1=CC=CC=C1)CC2=CC=CC3=CC=CC=C32.Cl, does not contain a chlorine atom. Therefore, the presence of a chlorine atom in the molecule is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: The molecule with label 0, CC(=O)SC1CC2=CC(=O)CCC2(C3C1C4CCC5(C4(CC3)C)CCC(=O)O5)C, contains a benzene ring. The molecule with label 1, Cl[Tl], does not contain a benzene ring. Therefore, the presence of a benzene ring in the molecule is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: The molecule with label 0, C1CN2C(=CC=C2C(=O)C3=CC=CC=C3)C1C(=O)O, contains a carbonyl group (-C=O). The molecule with label 1, CN1CCC(=C2C3=CC=CC=C3CCN4C2=NC=C4C=O)CC1, does not contain a carbonyl group (-C=O). Therefore, the presence of a carbonyl group (-C=O) in the molecule is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: The presence of a carbonyl group (C=O) in a molecule is a significant indicator of its potential to cause adverse effects.
2. Rule 2: The presence of a nitro group (-NO2) in a molecule is also a significant indicator of its potential to cause adverse effects.
3. Rule 3: The presence of a halogen atom (such as fluorine or chlorine) in a molecule is also a significant indicator of its potential to cause adverse effects.

================================

1. Rule 1: If a molecule contains a carboxylic acid group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a phenyl group, it is less likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains both a carboxylic acid group and a phenyl group, it is less likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If a molecule contains a functional group such as an amide or an imide group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a nitro group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects related to skin and respiratory system disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to central nervous system disorders.
These rules are based on the data provided and can be used to predict whether a new molecule is likely to cause adverse effects based on its structure. However, it is important to note that these rules are not foolproof and should be used with caution.

================================

1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carboxylic acid, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a functional group such as a chlorine atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
4. Rule 4: If a molecule contains a functional group such as a sulfur atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
5. Rule 5: If a molecule contains a functional group such as a phosphorus atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
6. Rule 6: If a molecule contains a functional group such as a nitrogen atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
7. Rule 7: If a molecule contains a functional group such as a fluorine atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
8. Rule 8: If a molecule contains a functional group such as a bromine atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
9. Rule 9: If a molecule contains a functional group such as a iodine atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
10. Rule 10: If a molecule contains a functional group such as a platinum atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If the molecule contains a functional group such as a carboxylic acid or a carbonyl group, it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to skin and respiratory system disorders.
3. Rule 3: If the molecule contains a nitro group, it is likely to cause adverse effects related to reproductive and developmental disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
These rules are based on the fact that the molecules with these functional groups are more likely to interact with biological molecules in the body and cause adverse effects. However, it is important to note that these rules are generalizations and may not apply to all molecules. It is always recommended to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
2. Rule 2: The presence of a hydroxyl group (-OH) in a molecule increases the risk of adverse effects on the blood and lymphatic system.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the risk of adverse effects on the blood and lymphatic system.

================================

1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the blood and lymphatic system, it is likely to cause similar effects in humans.
2. Rule 2: If a molecule contains a functional group that is known to cause adverse effects on the central nervous system, it is likely to cause similar effects in humans.
3. Rule 3: If a molecule contains a functional group that is known to cause adverse effects on the reproductive system, it is likely to cause similar effects in humans.
For example, the molecule with the smiles string "CC1OC2=C(O1)C=C(C=C2)C(C)(C)C" is likely to cause adverse effects on the blood and lymphatic system. The molecule with the smiles string "CC(C)(CC1=CC=CC=C1)N" is likely to cause adverse effects on the central nervous system. The molecule with the smiles string "CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N" is likely to cause adverse effects on the reproductive system.
The molecule with the smiles string "CN1C2CCC1CC(C2)OC(=O)C(C3=CC=CC=C3)O" is likely to cause adverse effects on the central nervous system. The molecule with the smiles string "C[C@@H]1CC[C@@]23CCC(=O)[C@H]2[C@@]1([C@@H](C[C@@]([C@H]([C@@H]3C)O)(C)C=C)OC(=O)CSC4C[C@H]5CC[C@@H](C4)N5C)C" is likely to cause adverse effects on the reproductive system.
The molecule with the smiles string "C1=CC(=CC(=C1)I)CN=C(N)N" is likely to cause adverse effects on the central nervous system. The molecule with the smiles string "CCC1(C(=O)NCNC1=O)C2=CC=CC=C2 1" is likely to cause adverse effects on the reproductive system.
The molecule with the smiles string "C[C@@H]1C[C@H]2C3C[C@@H](C4=

================================

1. Rule 1: If a molecule contains a functional group such as a carboxylic acid, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a functional group such as a chlorine atom, it is more likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a chlorine atom, it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a nitrogen atom, it is likely to cause adverse effects related to blood and lymphatic system disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule (CC1NC2=CC(=C(C=C2C(=O)N1C3=CC=CC=C3C)S(=O)(=O)N)Cl 1) contains a carbonyl group (C=O) and is labeled as 1, which means it is related to the side-effect activity of a molecule related to blood and lymphatic system disorders.
2. Rule 2: The second molecule (CCCC(=O)OC1(C(CC2C1(CC(=O)C3(C2CCC4=CC(=O)C=CC43C)F)C)C)C(=O)CCl 0) contains a chlorine atom and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to blood and lymphatic system disorders.
3. Rule 3: The third molecule (CN(C)CCC1=CNC2=C1C=C(C=C2)CN3C=NC=N3 0) contains a nitrogen atom and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to blood and lymphatic system disorders.
The fourth molecule (CCC(=C)C(=O)C1=C(C(=C(C=C1)OCC(=O)O)Cl)Cl 1) contains a carbonyl group (C=O) and is labeled as 1, which means it is related to the side-effect activity of a molecule related to blood and lymphatic system disorders.
The fifth molecule (C1C(C(C(C(C1N)OC2C(C(C(C(O2)CN)O)O)O)O)O)OC3C(C(C(C(O3)CO)O)N)O)N 0) contains a nitrogen atom and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to blood and lymphatic system disorders.
The sixth molecule (CCS(=O)(=O)CCN1C(=NC=C1[N+](=O)[O-])C 1) contains a sulfur atom and is labeled as 1, which means it is related to the side-effect activity of a molecule related to blood and lymphatic system disorders.
The seventh molecule (CC(C)(C1=CN=CC=C1)C(=O)C2=CN=CC=C2 1) contains a chlorine atom and is labeled as 1, which means it is related to the side-effect activity of a molecule related to blood and lymphatic system disorders.
The eighth molecule (CC1CNCCC2=C1C=C(C=C2)Cl 0) contains a chlorine atom and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to blood and lymphatic system disorders.
The ninth molecule (CC1=C(C=C(C=C1)C(=O)NC2=CC(=C(C=C2)CN3CCN(CC3)C)C(F)(F)F)C#CC4=CN=C5N4N=CC=C5 1) contains a chlorine atom and is labeled as 1, which means it is related to the side-effect activity of a molecule related to blood and lymphatic system disorders.
The tenth molecule (COC(=O)NC1=NC2=C(N1)C=C(C=C2)C(=O)C3=CC=CC=C3 1) contains a carbonyl group (C=O) and is labeled as 1, which means it is related to the side-effect activity of a molecule related to blood and lymphatic system disorders.
The eleventh molecule (CCCCNC1=C(C(=CC(=C1)C(=O)O)S(=O)(=O)N)OC2=CC=CC=C2 1) contains a nitrogen atom and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to blood and lymphatic system disorders.
The twelfth molecule ([O-2].[O-2].[O-2].[As+3].[As+3] 1) contains arsenic atoms and is labeled as 1, which means it is related to the side-effect activity of a molecule related to blood and lymphatic system disorders.
The thirteenth molecule (COC1C(CC2CN3CCC4=C(C3CC2C1C(=O)OC)NC5=C4C=CC(=C5)OC)OC(=O)C=CC6=CC(=C(C(=C6)OC)OC)OC 0) contains a carbonyl group (C=O) and is labeled as 0, which means it is not related to the side-effect activity of a molecule related to blood and lymphatic system disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a benzene ring, it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The first molecule ([H-].[H-].[Ba+2] 0) contains a benzene ring, which is known to be associated with adverse effects related to blood and lymphatic system disorders.
2. Rule 2: The second molecule (CC1C(OCCN1C)C2=CC=CC=C2 0) contains a carbonyl group (-C=O), which is known to be associated with adverse effects related to blood and lymphatic system disorders.
3. Rule 3: The third molecule (C1C(=O)NC2=C(C=C(C=C2)[N+](=O)[O-])C(=N1)C3=CC=CC=C3 1) contains a nitro group (-NO2), which is known to be associated with adverse effects related to blood and lymphatic system disorders.
The fourth molecule (C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N 1) also contains a nitro group (-NO2), but it is not directly related to blood and lymphatic system disorders.
The fifth molecule (CC(C)C1=C(C(=CC=C1)C(C)C)O 1) contains a benzene ring, but it is not directly related to blood and lymphatic system disorders.
The sixth molecule (CC[C@H](C)[C@H]1C(=O)N[C@H]2CSSC[C@@H](C(=O)N[C@@H](CSSC[C@@H](

================================

1. Rule 1: If a molecule contains a functional group such as an amide, imide, or urea group, it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a polycyclic aromatic hydrocarbon (PAH) structure, it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If a molecule contains a functional group such as an amide or a carboxylic acid, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a nitro group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If the molecule contains a carboxylic acid group, it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a platinum group metal, it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a halogenated aromatic ring, it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: The presence of a carbonyl group (C=O) in a molecule is a strong indicator of its potential to cause adverse effects.
2. Rule 2: The presence of a halogen atom (such as fluorine, chlorine, or bromine) in a molecule can also increase its potential to cause adverse effects.
3. Rule 3: The number and position of functional groups in a molecule can also affect its potential to cause adverse effects. For example, a molecule with multiple hydroxyl groups (-OH) may be more likely to cause adverse effects than a molecule with only one -OH group. Additionally, a molecule with a functional group in a specific position may be more likely to cause adverse effects than a molecule with the same functional group in a different position.

================================

Here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a sulfonamide group (-SO2NH2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
These rules are based on the data provided and can be used to predict whether a new molecule is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a sulfur atom (-S), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carboxylic acid, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a functional group such as a nitro group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a functional group such as a hydroxyl group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
These rules are based on the observation that molecules with these functional groups are more likely to interact with biological molecules and cause adverse effects. However, it is important to note that these rules are not definitive and there may be other factors that contribute to the adverse effects of a molecule.

================================

1. Rule 1: If a molecule contains a functional group such as an amide, sulfonamide, or carbamate, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a chiral center, it is more likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: The presence of a nitro group (-NO2) in a molecule increases the likelihood of causing adverse effects related to blood and lymphatic system disorders.
2. Rule 2: The presence of a carbonyl group (-C=O) in a molecule increases the likelihood of causing adverse effects related to blood and lymphatic system disorders.
3. Rule 3: The presence of a chlorine atom (-Cl) in a molecule increases the likelihood of causing adverse effects related to blood and lymphatic system disorders.
These rules can be inferred from the provided data by analyzing the structures of the molecules and their corresponding labels. The data shows that molecules with nitro and carbonyl groups are more likely to cause adverse effects related to blood and lymphatic system disorders, while molecules with chlorine atoms are also more likely to cause such effects. Therefore, these groups and atoms can be considered as potential predictors of adverse effects.

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a halogen atom (-F, -Cl, -Br, -I), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to skin and respiratory system disorders.
3. Rule 3: If the molecule contains a benzene ring (C6H5), it is likely to cause adverse effects related to skin and respiratory system disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The molecule with label 1, C[N+]1(CCC2=CC(=C(C=C2C1CC3=CC(=C(C=C3)OC)OC)OC)OC)CCC(=O)OCCCCCOC(=O)CC[N+]4(CCC5=CC(=C(C=C5C4CC6=CC(=C(C=C6)OC)OC)OC)OC)C, contains a nitro group (-NO2).
2. Rule 2: The molecule with label 1, C1=CC(=CC=C1CC(C(=O)O)N)N(CCCl)CCCl 1, contains a chlorine atom (-Cl).
3. Rule 3: The molecule with label 1, CC1C(C(CC(O1)OC2C(C(C(OC2OC3=C4C=C5C=C3OC6=C(C=C(C=C6)C(C(C(=O)NC(C(=O)NC5C(=O)NC7C8=CC(=C(C=C8)O)C9=C(C=C(C=C9C(NC(=O)C(C(C1=CC(=C(O4)C=C1)Cl)O)NC7=O)C(=O)O)O)O)O)CC(=O)N)NC(=O)C(CC(C)C)NC)O)Cl)CO)O)O)(C)N)O 1,

================================

1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a fluorine atom, it is more likely to cause adverse effects related to skin and subcutaneous tissue disorders.
3. Rule 3: If the molecule contains a chlorine atom, it is more likely to cause adverse effects related to respiratory, thoracic and mediastinal disorders.
These rules can be inferred by analyzing the structures and labels of the molecules provided in the data. For example, the first molecule contains a carbonyl group, which is known to be associated with adverse effects related to blood and lymphatic system disorders. Similarly, the second molecule contains a fluorine atom, which is known to be associated with adverse effects related to skin and subcutaneous tissue disorders. The third molecule contains a chlorine atom, which is known to be associated with adverse effects related to respiratory, thoracic and mediastinal disorders.

================================

1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a halogen atom (such as fluorine, chlorine, or bromine), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

1. Rule 1: If a molecule contains a functional group such as a carbonyl group (C=O) or a nitro group (-NO2), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a functional group such as a hydroxyl group (-OH), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a functional group such as a chlorine atom (Cl), it is more likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to skin and respiratory system disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to central nervous system disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The first molecule (C1=C(N=C(S1)N=C(N)N)CSCCC(=NS(=O)(=O)N)N) contains a nitro group (-NO2), which suggests that it may have adverse effects related to blood and lymphatic system disorders.
2. Rule 2: The second molecule (CN1C(CNC2=C1C(=O)N=C(N2)N)CNC3=CC=C(C=C3)C(=O)NC(CCC(=O)O)C(=O)O) contains a chlorine atom (-Cl), which suggests that it may have adverse effects related to skin and respiratory system disorders.
3. Rule 3: The third molecule (CCC1=C2C=C3C(=C(C(=CC4=NC(=CC5=NC(=CC(=C1C)N2)C(=C5CCC(=O)O)C)C(=C4C)CCC(=O)O)N3)C(C)O)C.[Na+]) contains a carbonyl group (-C=O), which suggests that it may have adverse effects related to central nervous system disorders.
Note that these rules are based on the provided data and may not be applicable to all cases. It is always important to consult with a qualified chemist before making any decisions based on these rules.

================================

1. Rule 1: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a chlorine atom, it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a phenyl group (C6H5), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
These rules can be inferred by analyzing the structures of the molecules and their possible interactions with biological systems. For example, the carboxylic acid group is commonly found in drugs and can interact with biological molecules such as proteins and enzymes, which can lead to adverse effects. Similarly, the phenyl group and nitro group can also interact with biological systems and cause adverse effects.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (C=O), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a guanidinium group (CN(C)CC(C1=CC=C(C=C1)O)C2(CCCCC2)O), it is not likely to cause adverse effects.
3. Rule 3: If the molecule contains a nitro group (N#[N+][O-]), it is likely to cause adverse effects.
These rules are based on the observation that the molecules with these functional groups are associated with specific adverse effects. However, it is important to note that these rules are not always accurate and should be used as a starting point for further analysis and experimentation.

================================

1. Rule 1: If a molecule contains a functional group such as an amide or a carboxylic acid, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a halogenated aromatic ring, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a nitro group, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
These rules are based on the analysis of the given data and the observation that molecules with these functional groups or structural features are more likely to cause adverse effects related to blood and lymphatic system disorders. However, it is important to note that these rules are not absolute and there may be other factors that contribute to the adverse effects of a molecule.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a chlorine atom (-Cl), it is likely to cause adverse effects related to skin and respiratory system disorders.
3. Rule 3: If the molecule contains a carbonyl group (-C=O), it is likely to cause adverse effects related to central nervous system disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with label 1, C[C@]12CCC3[C@H]([C@@H]1CC[C@@H]2C(=O)NC4=C(C=CC(=C4)C(F)(F)F)C(F)(F)F)CC[C@@H]5[C@@]3(C=CC(=O)N5)C, contains a nitro group (-NO2). This suggests that the molecule may have adverse effects related to blood and lymphatic system disorders.
2. Rule 2: The molecule with label 1, C1=NC(=O)NC(=C1F)N, contains a chlorine atom (-Cl). This suggests that the molecule may have adverse effects related to skin and respiratory system disorders.
3. Rule 3: The molecule with label 1, C1[C@@H]2C[C@@H]2N([C@@H]1C#N)C(=O)[C@H](C34C[C@H]5C[C@@H](C3)CC(C5)(C4)O)N.C(=O)(C(F)(F)F)O, contains a carbonyl group (-C=O). This suggests that the molecule may have adverse effects related to central nervous system disorders.

================================

1. Rule 1: If a molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If a molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If a molecule contains a halogen atom (-Cl, -Br, -I), it is likely to cause adverse effects related to blood and lymphatic system disorders.

================================

Based on the given data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carbonyl group (-C=O), it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a nitro group (-NO2), it is less likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a hydroxyl group (-OH), it is less likely to cause adverse effects related to blood and lymphatic system disorders.
These rules can be inferred from the given data as follows:
1. Rule 1: The molecule with label 1, "CCNC(=O)N(CCCN(C)C)C(=O)C1CC2C(CC3=CNC4=CC=CC2=C34)N(C1)CC=C", contains a carbonyl group (-C=O). Therefore, it is more likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: The molecule with label 0, "CN1C2CCC1CC(C2)OC(=O)C(CO)C3=CC=CC=C3 1", contains a nitro group (-NO2). Therefore, it is less likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: The molecule with label 0, "CC1=CN(C(=O)NC1=O)[C@H]2C[C@@H]([C@H](O2)COP(=O)([O-])S[C@H]3C[C@@H](O[C@@H]3COP(=O)([O-])S[C@H]4C[C@@H](O[C@@H]4COP(=O)([O-])S[C@H]5C[C@@H](O[C@@H]5COP(=O)([O-])S[C@H]6C[C@@H](O[C@@H]6COP(=O)([O-])S[C

================================

Based on the provided data, here are three rules that directly relate the properties/structures of a molecule to predict whether it is can cause adverse effect:
1. Rule 1: If the molecule contains a carboxylic acid group (-COOH), it is likely to cause adverse effects related to blood and lymphatic system disorders.
2. Rule 2: If the molecule contains a phenyl group (C6H5), it is likely to cause adverse effects related to blood and lymphatic system disorders.
3. Rule 3: If the molecule contains a nitro group (-NO2), it is likely to cause adverse effects related to blood and lymphatic system disorders.
These rules can be inferred from the provided data as follows:
1. Rule 1: The molecule C1[C@H](CN2[C@@H]1C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C2=O)CC3=CC=CC=C3)CC4=CC=C(C=C4)OCC5=CC=CC=C5)CCCCN)CC6=CNC7=CC=CC=C76)C8=CC=CC=C8)OC(=O)NCCN 1 contains a carboxylic acid group (-COOH).
2. Rule 2: The molecule C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)NN.C1=CC(=C(C=C1C[C@@H](C(=O)O)N)O)O 1 contains a phenyl group (C6H5).
3. Rule 3: The molecule CC(C)[C@@H](C(=O)OCC(CO)OCN1C=NC2=C1NC(=NC2=O)N)N 1 contains a nitro group (-NO2).

================================

1. Rule 1: If a molecule contains a functional group that is known to cause adverse effects on the blood and lymphatic system, such as a sulfonamide group, it is likely to cause adverse effects.
2. Rule 2: If a molecule contains a functional group that is known to cause adverse effects on the central nervous system, such as a quinolone group, it is likely to cause adverse effects.
3. Rule 3: If a molecule contains a functional group that is known to cause adverse effects on the skin, such as a benzimidazole group, it is likely to cause adverse effects.
These rules are based on the observation that molecules with these functional groups are more likely to cause adverse effects than molecules without them. However, it is important to note that these rules are not foolproof and there may be exceptions to them. It is always best to consult with a qualified chemist before making any decisions based on these rules.

================================

